Alternatives to Elmiron Use

Event News

Researcher: Ariana Arce​

Researcher: Ariana Arce​

a.arce@legalhelpadvisor.com

Journalist: Aaron Vivanco

Journalist: Aaron Vivanco

a.vivanco@legalhelpadvisor.com

Editor: Daniela Polo

Editor: Daniela Polo

d.polo@legalhelpadvisor.com

Contact Us

We will review your case so that we can help you become a part of the lawsuit to hold the company accountable.

Alternatives to Elmiron Use

Elmiron is an oral medication prescribed for interstitial cystitis (IC); however, recent discoveries have demonstrated serious health risks associated with its use. Hence, alternative options should be considered if you have been taking this medication.

A bottle of Elmiron medication ready to be used.

Dangers of Elmiron use

Elmiron has been approved by the Food and Drug Administration (FDA) as a treatment option for IC, a condition that can cause bladder pain, pelvic pain, and urinary urgency.

Studies have shown a correlation between Elmiron use and negative effects on vision and eyesight. A study reported that 25% of patients who used Elmiron experienced eye damage.

Elmiron has been associated with potential harm to the retina, including risks of macular degeneration. Other dangerous side effects include the following:

  • Vision loss
  • Vision impairment
  • Halo vision
  • Blurred vision
  • Complete or total blindness

Besides its contentious nature, the drug has some adverse effects, including nausea and hair loss. For those who need continuous treatment for their IC while avoiding potential side effects of Elmiron, there are alternatives available.

The FDA warns about Elmiron on the product label

In 2020, Elmiron manufacturers updated its packaging to provide information regarding the potential risks of pigmentary maculopathy for individuals using the drug. Despite the association between Elmiron and maculopathy, an Elmiron recall was not immediately implemented. However, the warning label on the product may have helped prevent some cases of vision loss.

Patients who have taken Elmiron should be aware of the potential risks of post-discontinuation vision problems. Scheduling regular appointments with an eye doctor and familiarizing with symptoms of retinal damage should be considered precautionary measures.

Alternatives to consider before consuming Elmiron

The Mayo Clinic suggests the following various oral alternative medications for the potential treatment of IC:

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly utilized for pain relief and can be purchased at most grocery stores. Specifically, ibuprofen and naproxen have been found to effectively treat IC-related pain.

Tricyclic antidepressants, such as imipramine or amitriptyline, have been found to alleviate bladder pain and improve IC management.

For those who take medication for seasonal allergies, antihistamines may provide relief for IC symptoms. Choosing a medication containing loratadine can alleviate symptoms, such as discomfort and frequent urination commonly associated with IC.

Furthermore, several other safe alternatives may potentially be used as Elmiron alternatives, including physical therapy or others:

  • Nerve stimulation techniques, such as transcutaneous electrical nerve stimulation or sacral nerve stimulation, are commonly used.
  • Bladder distention is a stretching procedure performed during cystoscopy surgery.
  • Bladder instillation (using a medication like Rimso-50 or dimethyl sulfoxide delivered directly by a bladder catheter).

In rare cases, a doctor may recommend surgery as an Elmiron alternative to treat IC. Possible surgeries include fulguration, resection, and bladder augmentation. Under no circumstances, patients should resort to illegal drugs to relieve bladder pain.

What steps do I have to take if I previously consumed Elmiron?

Research indicates that Elmiron may cause long-term eye damage, even after discontinuing use. Individuals experiencing any symptoms or side effects while taking Elmiron should seek advice from their healthcare professionals.

Patients who believe they were harmed by Elmiron have the option to file a lawsuit against the drug’s manufacturer to seek accountability and protect their legal interests.

If someone experiences eye problems or symptoms after taking Elmiron for IC, it may prevent harm to other patients if they report it and take legal action. Our team can assist with the necessary steps in pursuing this.

Elmiron class action lawsuit

There are ongoing lawsuits related to Elmiron, a drug that allegedly may cause maculopathy and other retinal disorders that lead to blindness, affecting the plaintiffs’ quality of life. Although a significant number of people are being exposed to this drug, it remains available for purchase.

According to the lawsuits, Elmiron, a drug used for IC, is considered defective. The plaintiffs allege that Janssen did not disclose adverse event reports to the public, medical community, and the US FDA.

Studies have revealed a potential link between Elmiron medication and retinal damage, resulting in product liability lawsuits against Janssen Pharmaceutical for vision loss associated with Elmiron use.

Those who have experienced maculopathy due to Elmiron use can pursue compensation from the manufacturer for any related losses or costs.

For more details about this case, you can have a look at our Elmiron Class Action Lawsuit information page.

What are the eligibility requirements for an Elmiron lawsuit?

Legal action may be pursued if you have been diagnosed with eye diseases after taking Elmiron for a minimum of 2 years. Eligibility will be evaluated by our expert Elmiron lawyers.

If you meet the following certain requirements, you can take legal action against Elmiron:

  • Took Elmiron for at least 2 years.
  • Sought medical treatment for vision issues.
  • Suffered vision changes, such as blurred vision, difficulty reading, distorted vision, eye pain, issues adjusting to the darkness, vision disturbances, or vision loss after taking Elmiron.
  • Were diagnosed with vision problems or started having vision problems while taking or within 1 year of stopping the medication.
  • Started having vision problems on or after January 1, 2010.

It is recommended to consult a lawyer to determine eligibility for filing a lawsuit associated with Elmiron. If unsure about meeting the criteria, contact an Elmiron lawyer for clarification. The consultation is free, and eligibility can be determined by answering a few questions.